246 related articles for article (PubMed ID: 23867798)
1. RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.
Logan M; Anderson PD; Saab ST; Hameed O; Abdulkadir SA
Am J Pathol; 2013 Sep; 183(3):951-63. PubMed ID: 23867798
[TBL] [Abstract][Full Text] [Related]
2. ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.
Jin F; Irshad S; Yu W; Belakavadi M; Chekmareva M; Ittmann MM; Abate-Shen C; Fondell JD
Mol Cancer Res; 2013 Jul; 11(7):736-47. PubMed ID: 23538858
[TBL] [Abstract][Full Text] [Related]
3. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer.
Thangapazham R; Saenz F; Katta S; Mohamed AA; Tan SH; Petrovics G; Srivastava S; Dobi A
BMC Cancer; 2014 Jan; 14():16. PubMed ID: 24418414
[TBL] [Abstract][Full Text] [Related]
4. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
[TBL] [Abstract][Full Text] [Related]
5. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of loss of
Le Magnen C; Virk RK; Dutta A; Kim JY; Panja S; Lopez-Bujanda ZA; Califano A; Drake CG; Mitrofanova A; Abate-Shen C
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266798
[TBL] [Abstract][Full Text] [Related]
7. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis.
Anderson PD; McKissic SA; Logan M; Roh M; Franco OE; Wang J; Doubinskaia I; van der Meer R; Hayward SW; Eischen CM; Eltoum IE; Abdulkadir SA
J Clin Invest; 2012 May; 122(5):1907-19. PubMed ID: 22484818
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells.
Zhang PJ; Hu XY; Liu CY; Chen ZB; Ni NN; Yu Y; Yang LN; Huang ZQ; Liu QW; Jiang AL
Asian J Androl; 2012 May; 14(3):493-8. PubMed ID: 22179513
[TBL] [Abstract][Full Text] [Related]
9. Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma.
Dallmayer M; Li J; Ohmura S; Alba Rubio R; Baldauf MC; Hölting TLB; Musa J; Knott MML; Stein S; Cidre-Aranaz F; Wehweck FS; Romero-Pérez L; Gerke JS; Orth MF; Marchetto A; Kirchner T; Bach H; Sannino G; Grünewald TGP
Cell Death Dis; 2019 Feb; 10(2):116. PubMed ID: 30741933
[TBL] [Abstract][Full Text] [Related]
10. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
Linn DE; Bronson RT; Li Z
PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
[TBL] [Abstract][Full Text] [Related]
11. Regulated expression of the TPβ isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer.
O'Sullivan AG; Eivers SB; Mulvaney EP; Kinsella BT
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3153-3169. PubMed ID: 28890397
[TBL] [Abstract][Full Text] [Related]
12. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
13. [A multi-omics study on NKX3.1-related node genes in prostate cancer].
Mo LJ; Su SQ; Gu YM; Hy YL
Zhonghua Nan Ke Xue; 2016 Apr; 22(4):294-9. PubMed ID: 30088395
[TBL] [Abstract][Full Text] [Related]
14. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
[TBL] [Abstract][Full Text] [Related]
15. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
[TBL] [Abstract][Full Text] [Related]
16. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
[TBL] [Abstract][Full Text] [Related]
17. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
18. NKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferation.
Muhlbradt E; Asatiani E; Ortner E; Wang A; Gelmann EP
Cancer Res; 2009 Mar; 69(6):2615-22. PubMed ID: 19258508
[TBL] [Abstract][Full Text] [Related]
19. Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner.
Zhou J; Qin L; Tien JC; Gao L; Chen X; Wang F; Hsieh JT; Xu J
J Biol Chem; 2012 May; 287(21):17248-17256. PubMed ID: 22465996
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.
Abdulkadir SA
Ann N Y Acad Sci; 2005 Nov; 1059():33-40. PubMed ID: 16382041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]